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Efficacy of metoclopramide and dexamethasone for 
postoperative nausea and vomiting: a double-blind 
clinical trial
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ABSTRACT Postoperative nausea and vomiting are common complications of anaesthesia. This double-blind 
clinical trial assessed the incidence of nausea and vomiting after cataract surgery with intravenous anaesthesia 
in 100 patients randomly assigned to preinduction placebo (saline), metoclopramide (10 mg), dexamethasone 
(8 mg) or the 2 drugs combined. The incidence of nausea in the recovery room was 44% with placebo, 20% with 
metoclopramide, 16% with dexamethasone and 8% with the combination. The incidence of vomiting was 20%, 
4%, 4% and 0% respectively in the 4 groups. Metoclopramide plus dexamethasone combination significantly 
decreased nausea and vomiting both in the recovery room and 24 hours afterwards and is recommended for 
high-risk groups, especially in outpatient surgeries.
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 )ةيكينيلكإ( ةيريسر ةسارد :ةيحارلجا تايلمعلا ولت ءيقلاو نايثغلا ةلجاعم في نوزاثيماسكيدو ديماربولكوتيلما )ةءافك( ةعاجن
ةيمعتلا ةجودزم
يبركأ ناوخا تردق ،رف هداز ىسيع هرطاخ ،نطاب شوخ رهجونم ،لصأ يراظتنا دوعسم
 لدعم ،ةيمعتلا ةجودزلما )ةيكينيلكلإا( ةيريسرلا ةساردلا هذه في نوثحابلا مِّيقيو .ريدختلا تافعاضم في ءيقلاو نايثغلا ثودح عيشي :ةـصلالخا
 مهئاطعلإ ًايئاوشع نوثحابلا  مهنيع ضيرم ةئم  ىدل يديرولا  ريدختلا  عم )تكاراتكلا(  داسلا  حدقل  ةحارج ءارجإ دعب  ،ءيقلاو نايثغلا  ثودح
 نوزاثيماسكيدلا  نم مارغ لييم 8  وأ  ديماربولكوتيلما  نم مارغ لييم 10  مهئاطعلإ وأ  ،ريدختلل  يرضحتلا  دنع )يحلم لولمح( placebo  لقع ءاود
 ىدلو ،%20 ديماربولكوتيلما يطعأ نم ىدلو ،%44 لقعلا ءاودلا يطعأ نم ىدل ةقافلإا ةفرغ في نايثغلا ثودح لدعم غلب دقو .ًاعم ينئاودلا وأ
 نم ىدلو ،%20 لقعلا ءاودلا يطعأ نم ىدل ناكف ءيقلا ثودح لدعم امأ .%8 ًاعم ينئاودلا يطعأ نم ىدلو %16 نوزاثيماسكيدلا يطعأ نم
 ديماربولكوتيلما ةفيلوت ءاطعإ نأ حضتا اذكهو .%0 ًاعم ينئاودلا يطعأ نم ىدلو %4 نوزاثيماسكيدلا يطعأ نم ىدلو ،%4 ديماربولكوتيلما يطعأ
 هذه لماعتساب صيوي اذل ،كلذ نم ةعاس 24  دعبو ةقافلإا ةفرغ في ءيقلاو نايثغلا ثودح نم ًايئاصحإ هب ُّدَتْعُي  رادقمب صِقنُي نوزاثيماسكيدلاو
.ينيجرالخا ضىرملل تاحارلجا في ماَّيسلاو عفترم رطلخ ةضرعلما ةعومجلما ىدل ةفيلوتلا
Efficacité du métoclopramide et de la dexaméthasone sur les nausées et vomissements postopératoires : une 
étude clinique en double aveugle
RÉSUMÉ Les nausées et vomissements postopératoires sont des complications courantes de l’anesthésie. 
Cette étude clinique en double aveugle évaluait l’incidence des nausées et des vomissements après une 
chirurgie de la cataracte avec anesthésie par voie intraveineuse chez 100 patients auxquels un placebo (eau 
saline), du métoclopramide (10 mg), de la dexaméthasone (8 mg) ou les deux médicaments associés avaient 
été administrés de manière randomisée avant l’opération. L’incidence des nausées en salle de réveil était de 
44 % avec le placebo, 20 % avec le métoclopramide, 16 % avec la dexaméthasone et 8 % avec l’association 
des deux médicaments. L’incidence des vomissements était de 20 %, 4 %, 4 % et 0 %, respectivement, dans 
les quatre groupes. L’association du métoclopramide et de la dexaméthasone a considérablement réduit les 
nausées et vomissements, non seulement en salle de réveil mais également dans les 24 heures qui suivent, et est 
recommandée pour les groupes à haut risque, notamment pour les patients opérés en ambulatoire.




Postoperative nausea and vomiting 
(PONV) is one of the most common 
complications of anaesthesia [1]. De-
spite significant improvements in thera-
peutics and anaesthesia techniques, the 
rate of this complication still remains 
high. PONV afflicts around one-third 
of patients undergoing operation with 
general anaesthesia [2], and can lead to 
wound dehiscence, bleeding, aspiration 
of gastric contents, water and electrolyte 
abnormalities, prolonged hospitaliza-
tion, rehospitalization and patients’ low 
satisfaction with postoperative care [3]. 
It is so unpleasant that most patients 
would prefer to experience postopera-
tive pain rather than nausea and vomit-
ing [4].
Occurrence of PONV is influenced 
by various factors such as duration of 
anaesthesia, type of surgery, use of nar-
cotics, patient’s age and sex, and history 
of PONV, motion sickness or smoking 
[4]. Cataract surgery, however, has not 
been reported to increase postoperative 
nausea and vomiting. Evidence shows 
that PONV may be prevented by using 
prophylactic injection of certain drugs 
[5]. Dexamethasone and metoclopra-
mide are commonly used separately 
for this purpose, and most studies have 
demonstrated their efficacy in decreas-
ing PONV [6–8]. In the current study, 
the effect of preoperative injection of 
dexamethasone, metoclopramide and 
their combination on PONV was in-
vestigated.
Methods
The study was a double-blind clinical 
trial. The study group was 100 patients 
referred to Alavi Hospital in Ardebil 
(northwest of Islamic Republic of Iran) 
for cataract surgery under general anaes-
thesia who met the American Society of 
Anesthesiologists’ physical status classi-
fication class 1 (normal healthy patient) 
or 2 (patient with mild systemic disease). 
The sample size was calculated based on 
probability of reducing PONV by 40%, 
with α = 0.05 and β = 20%. The baseline 
exclusion criteria were: suffering from 
diabetes mellitus or other underlying 
disorders, use of antiemetics during the 
past 24 hours and a positive history of 
motion sickness or PONV.
Patients were enrolled 1 hour before 
going to the operating room and only if 
they agreed to participate in the study af-
ter it had been fully explained them and 
they signed an informed consent form. 
This was prepared by the ethical com-
mittee of Ardebil University of Medical 
Sciences and allowed participants to 
withdraw at any point in the study no 
explanation and without jeopardizing 
the quality of care they received. 
The patients were randomly as-
signed by block randomization to one 
of 4 groups of 25 patients: placebo (2 
mL normal saline); metoclopramide 
(10 mg); dexamethasone (8 mg); or 
metoclopramide plus dexamethasone 
(10 mg/8 mg). All the treatments were 
given intravenously 1 minute before 
induction of anaesthesia by injection 
of fentanyl (2 μg/kg), propofol (2 mg/
kg) and atracurium (0.5 mg/kg). They 
were given by the anaesthetist who was 
unaware of the drug allocation. Follow-
ing tracheal intubation, anaesthesia was 
continued with an infusion of propo-
fol  (50 μg/kg/min) while  the patient 





O  (50%).  Local  anaesthetics 
were not applied during surgery.
The duration of surgery was almost 
the same (i.e. range of 35–40 minutes) 
for all patients. Following surgery, pa-
tients were transferred to the recovery 
room, where the incidence of PONV 
and the frequency of those needing 
treatment for PONV were evaluated by 
nurses, who were blind to the patient’s 
group as the drug administered was 
not recorded on the patient’s anaes-
thesia chart. The occurrence of PONV 
was also  recorded 24 hours  following 
surgery. Nausea and vomiting were re-




cataract surgery is relatively slight, pa-
tients did not receive further analgesic 
treatment after discharge. Any patient 
experiencing moderate to severe pain 
(score ≥ 5) would receive 50 mg pethi-
dine and be ineligible to finish the study; 
however no cases were reported. 
The data were analysed using SPSS, 
version 13.0. A series of 1-way analyses 
of variance were conducted to exam-
ine differences between  the 4  groups 
with respect to parametric variables. If 
a  significant difference was  found,  the 
Bonferroni t-test was used to detect 
intergroup differences. Categorical vari-
ables were analysed by using a series of 
4 × 2 chi-squared tests to determine the 
differences between the 3 treatment 





ground characteristics of patients in the 
4 groups  in  terms of age,  sex, duration 
of surgery or history of smoking (Table 
1).
The incidence of nausea and vomit-
ing in the recovery room and 24 hours 
after the operation is shown in Table 2. 
Patients in the metoclopramide, dexam-
ethasone and combination groups had 
a lower incidence of nausea (20%, 16% 
and 8%  respectively)  in  the  recovery 
room when compared with the placebo 
group (44%). The incidence of vomiting 
in  the  recovery  room was 4%, 4% and 
0%  respectively  compared with  20% 
in the placebo group. Although both 
metoclopramide and dexamethasone 
separately were effective in reducing 
the symptoms of PONV, the difference 
was only statistically  significant  for  the 
combination. Similar results were found 
after 24 hours (Table 2). 
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There was no significant difference 
in the incidence of nausea and vomit-
ing between males and females in the 
4  study groups  (data not  shown, P = 
0.76). 
The intensity of postoperative pain 






difference was observed in any of the 
3 treatment groups (i.e. metoclopra-
mide, dexamethasone or combination) 
in terms of the frequency of need for 
postoperative analgesics.
Discussion
PONV is still among the most com-
mon and troublesome complications 
of surgery, causing delays in patient dis-
charge from hospital, especially in out-
patient surgeries. Therefore, therapeutic 
strategies preventing this complication 
are of utmost importance [9]. Replacing 
nitrous oxide with intravenous propofol 
has reduced, but not eliminated, the 
incidence of PONV [10,11]. In the 
current study, the preventive effect of 
metoclopramide, dexamethasone and 
their combination in decreasing PONV 
in elderly people undergoing cataract 
surgery was investigated. The results 
of this study showed that although pa-
tients given metoclopramide or dexam-
ethasone alone had a lower incidence of 
PONV, the effect was not statistically 
significant whereas their combined use 
had a significant effect. The incidence of 
nausea with metoclopramide plus dex-
amethasone was 8% versus 44% with 




Some previous placebo-controlled 
studies have also demonstrated the 
preventive effect of preoperative use of 
dexamethasone (especially in combina-
tion with metoclopramide) on PONV. 
In 204 patients undergoing lumbar disc 
surgery, Wallenborn et al. showed that 
while the incidence of nausea and vom-
iting was 35.8% in the placebo group, the 
preoperative use of combined metoclo-
pramide and dexamethasone decreased 
the incidence of postoperative nausea 
to 10% and vomiting to 3% [12]. In an-
other study by Feo et al. on laparoscopic 
surgery patients, the incidence of nausea 
and vomiting was 46%  in  the placebo 
group and 14%  in  the dexamethasone 
group [13]. Laiq et al., in a study on 
100  patients  undergoing  gynaeco-
logical surgery, found that nausea and 
vomiting decreased from 30% and 24% 
Table 1 Age, sex, duration of surgery and history of smoking in the 4 patient groups





dexamethasone (n = 
25)
P-valuea
Age [mean (SD) years]b 67.1 (9.3) 61.5 (10.1) 65.9 (11.4) 71 (5.9) 0.80
Sex [no. (%)]
Female 13( 52) 10 (40) 11 (44) 14 (56)
0.70
Male 12 (48) 15 (60) 14 (56) 11 (44)
Duration of surgery 
 [mean (SD) min] 36.2 (2.3) 38.5 (1.8) 35.4 (1.1) 37.2 (2.4) 0.65
History of smoking 
 [no. (%)] 3 (12) 5 (20) 3 (12) 3 (12) 0.09
aChi-squared test and ANOVA; bRange 50 to 80 years. 
SD = standard deviation.
Table 2 Incidence of nausea and vomiting in the recovery room, and after 24 hours in the 4 patient groups 
Group Placebo (n = 
25)
Metoclopramide (n = 25) Dexamethasone (n = 25) Metoclopramide + 
dexamethasone (n = 25)
% % P-valuea % P-valuea % P-valuea
In recovery room
 Nausea 44 20 0.72 16 0.65 8 0.01
 Vomiting 20 4 0.55 4 0.55 0 0.02
After 24 hours
 Nausea 52 20 0.68 20 0.68 8 0.008
 Vomiting 20 4 0.55 4 0.55 0 0.02
aCompared with the placebo group by the chi-squared test.




with dexamethasone [14]. According 
to Huang  et  al.,  5 mg dexamethasone 
significantly decreased  the  incidence of 
PONV  from  70%  to  28%  [15], while 




In contrast, Chekman et al., compar-
ing the effect of dexamethasone and 
metoclopramide (injected 10 minutes 
before  anaesthesia)  in  45  patients 
divided into 3 groups, showed that 
PONV incidence was not significantly 
different between the dexamethasone 
and metoclopramide groups [17]. The 
difference between our results and 
theirs was probably due to the time of 
drug injection, since its effect on PONV 
might be diminished due to the short 
half-life of the drug. The limited number 
of patients in Chekman’s study was their 
main limitation. 
Our study has some limitations 
that might  have  influenced  the  find-
ings. First, our sample size was small. 
Second, the study was conducted only 
in patients undergoing cataract surgery. 
Third, it was conducted only in older 
patients. However, our study protocol 
was a strong point. 
In conclusion, although prophylac-
tic  injection of 10 mg metoclopramide 
or  8  mg  dexamethasone  separately 
can decrease the incidence of PONV, 
the combined use of these drugs has a 
more marked and significant effect.  In 
view of the low cost of these drugs, their 
combined prophylactic use is recom-
mended in the groups at risk for PONV, 
especially in outpatient surgeries.
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